Prdx3-flox Mouse
一般名
Prdx3-flox
製品ID
S-CKO-01214
背景情報
C57BL/6JCya
系統ID
CKOCMP-11757-Prdx3-B6J-VA
状況
このマウス系統を論文で使用する場合は、「Prdx3-flox Mouse(カタログ番号S-CKO-01214)はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Prdx3-flox
系統ID
CKOCMP-11757-Prdx3-B6J-VA
遺伝子名
製品ID
S-CKO-01214
遺伝子別名
Aop1, Ef2l, Mer5, Prx3, SP22, TDXM, D0Tohi1
遺伝子別名
C57BL/6JCya
NCBI ID
修正
Conditional knockout
染色体
Chr 19
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000025961
NCBIトランスクリプトID
NM_007452
ターゲット領域
Exon 2
有効領域の大きさ
~1.3 kb
遺伝子研究の概要
Prdx3, peroxiredoxin 3, is a master regulator of mitochondrial oxidative stress. It functions as an efficient hydrogen peroxide (H₂O₂) scavenger, protecting cells from mitochondrial oxidative damage and apoptosis. It is involved in multiple biological pathways, such as those related to oxidative stress response, ferroptosis, and cell survival [1,2].
In animal models, Prdx3 has been shown to play significant roles in various diseases. In liver fibrosis, its expression is negatively correlated with the condition. PRDX3 knockdown in mice exacerbated hepatic fibrogenesis and hepatic stellate cell (HSC) activation, while HSC-specific PRDX3 overexpression attenuated liver fibrosis, with the mechanism involving the mitochondrial reactive oxygen species (ROS)/TGF-β1/Smad2/3 pathway [1].
In intestinal ischemia/reperfusion (I/R) injury, PRDX3 expression was decreased. Overexpression of PRDX3 in Caco-2 cells significantly attenuated hypoxia/reoxygenation (H/R)-induced mitochondrial oxidative damage and apoptosis. SIRT3-mediated deacetylation of PRDX3 was found to alleviate I/R-induced mitochondrial oxidative damage and apoptosis [2].
In pulmonary fibrosis, YAP1 promoted Prdx3 expression, and forced expression of Prdx3 inhibited senescence and improved mitochondrial dysfunction in bleomycin-treated MLE-12 cells, while Prdx3 depletion abrogated the protective effect of YAP1 [3].
In gastric cancer, PRDX3 was overexpressed in cancer tissue compared to adjacent non-cancer tissue. Silencing PRDX3 reduced the half-inhibitory concentration (IC50) of cisplatin in AGS and MKN-74 cell lines, increased apoptosis, and upregulated the expression of cleaved caspase-3 and Bax, indicating that PRDX3 increases cisplatin resistance in gastric cancer cells [4].
In uveal melanoma, high immunohistochemical expression of PRDX3 in primary tissue was associated with metastasis and poor survival [5]. In gastric cancer, the FOXM1-ASF1B-PRDX3 axis was identified, and ASF1B regulated PRDX3 transcription in a FOXM1-dependent manner, with PRDX3 playing a role in cell proliferation and oxidative stress balance [6].
In conclusion, Prdx3 is crucial for maintaining mitochondrial function and cell survival by scavenging H₂O₂. Studies using gene-knockout or conditional-knockout mouse models have revealed its significance in diseases like liver fibrosis, intestinal I/R injury, pulmonary fibrosis, gastric cancer, and uveal melanoma. These findings provide potential therapeutic targets for treating these diseases by targeting Prdx3 and its related pathways.
References:
1. Sun, Ruimin, Tian, Xinyao, Li, Yang, Zheng, Shusen, Yao, Jihong. 2022. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. In Redox biology, 54, 102378. doi:10.1016/j.redox.2022.102378. https://pubmed.ncbi.nlm.nih.gov/35779442/
2. Wang, Zhanyu, Sun, Ruimin, Wang, Guangzhi, Yao, Jihong, Tian, Xiaofeng. 2019. SIRT3-mediated deacetylation of PRDX3 alleviates mitochondrial oxidative damage and apoptosis induced by intestinal ischemia/reperfusion injury. In Redox biology, 28, 101343. doi:10.1016/j.redox.2019.101343. https://pubmed.ncbi.nlm.nih.gov/31655428/
3. Su, Wei, Guo, Yingying, Wang, Qianqian, Shan, Hongli, Liang, Haihai. 2024. YAP1 inhibits the senescence of alveolar epithelial cells by targeting Prdx3 to alleviate pulmonary fibrosis. In Experimental & molecular medicine, 56, 1643-1654. doi:10.1038/s12276-024-01277-0. https://pubmed.ncbi.nlm.nih.gov/38945958/
4. Yan, Hao, Cai, Xinyu, Fu, Shanshan, Zhang, Xiubin, Zhang, Jianna. . PRDX3 promotes resistance to cisplatin in gastric cancer cells. In Journal of cancer research and therapeutics, 18, 1994-2000. doi:10.4103/jcrt.jcrt_970_22. https://pubmed.ncbi.nlm.nih.gov/36647961/
5. Ramasamy, Pathma, Larkin, Anne-Marie, Linge, Annett, Kennedy, Susan, Meleady, Paula. 2019. PRDX3 is associated with metastasis and poor survival in uveal melanoma. In Journal of clinical pathology, 73, 408-412. doi:10.1136/jclinpath-2019-206173. https://pubmed.ncbi.nlm.nih.gov/31771972/
6. Zhao, Zhou, Cai, Zhaolun, Zhang, Su, Han, Junhong, Zhang, Bo. 2024. Activation of the FOXM1/ASF1B/PRDX3 axis confers hyperproliferative and antioxidative stress reactivity to gastric cancer. In Cancer letters, 589, 216796. doi:10.1016/j.canlet.2024.216796. https://pubmed.ncbi.nlm.nih.gov/38537775/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。
